Exosome is focused on developing and commercializing biofluid-based diagnostics solutions to deliver personalized precision healthcare.
$16M
Jan 06, 2016
Jun 01, 2018
Protagen develops diagnostic tools for the treatment of autoimmune diseases.
$4.7M
Dec 15, 2014
Mar 01, 2019
Curetis is a molecular diagnostics company that develops tools to test infectious diseases.
$18M
Nov 23, 2014
Sep 01, 2019
AYOXXA is a Germany-based biotechnology company that develops and markets protein analysis assays for drug discovery and translational research applications.
$12.3M
Jun 29, 2014
-
Exosome is focused on developing and commercializing biofluid-based diagnostics solutions to deliver personalized precision healthcare.
$27.1M
Mar 10, 2014
Jun 01, 2018
Frequently Asked Questions about QIAGEN
What is QIAGEN investing in?
QIAGEN has invested in 6 companies including Exosome Diagnostics, Protagen and Curetis
What company did QIAGEN invest in?
QIAGEN invested in a total 6 companies including Exosome Diagnostics, Protagen and Curetis
What are the top 5 investments by QIAGEN?
The top companies in which QIAGEN invested are Exosome Diagnostics, Protagen, Curetis, AYOXXA and Exosome Diagnostics
